PHAT – phathom pharmaceuticals, inc. (US:NASDAQ)
Stock Stats
News
Phathom Pharmaceuticals (NASDAQ:PHAT) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald.
Should Phathom's US$130 Million Equity Raise and Profitability Timeline Update Require Action From Phathom Pharmaceuticals (PHAT) Investors? [Yahoo! Finance]
Phathom: Why I'm Not Buying The Dip (Yet) [Seeking Alpha]
Phathom Pharmaceuticals Announces Pricing of $130 Million Public Offering of Common Stock and Pre-Funded Warrants
Phathom Pharmaceuticals Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
Form 4 Phathom Pharmaceuticals, For: Jan 13 Filed by: Parikh Asit
Form 8-K Phathom Pharmaceuticals, For: Jan 07
Form 424B5 Phathom Pharmaceuticals,
Form 424B5 Phathom Pharmaceuticals,
Form 8-K Phathom Pharmaceuticals, For: Jan 07
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.